Amarin Corp. PLC ADR | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
296.35 M |
Public Float |
- |
Amarin Corp. PLC ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.38 |
Market Cap |
$7.66 B |
Shares Outstanding |
330.64 M |
Public Float |
288.38 M |
Address |
2 Pembroke House Dublin Dublin 2 Ireland |
Employees | - |
Website | http://amarincorp.com |
Updated | 07/08/2019 |
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. |